Finance

Lists
KRKG:VIE
Krka dd Novo Mesto
€260.00
-0.38%
(-1.00) 1D
Sep 29, 5:36:00 PM GMT+2  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for KRKG...
Open
€261.00
High
€261.00
Low
€260.00
Mkt. cap
8.54B
Avg. vol.
0.00
Volume
0.00
Dividend
3.50%
Quarterly dividend
€2.28
Ex-dividend date
Jul 21, 2026
P/E ratio
18.75
52-wk high
€273.00
52-wk low
€224.00
EPS
€13.86
No. of employees
13K
Open
€261.00
High
€261.00
Low
€260.00
Mkt. cap
8.54B
Avg. vol.
0.00
Volume
0.00
Dividend
3.50%
Quarterly dividend
€2.28
Ex-dividend date
Jul 21, 2026
P/E ratio
18.75
52-wk high
€273.00
52-wk low
€224.00
EPS
€13.86
No. of employees
13K
Profile
Krka, d. d., Novo mesto is an international generic pharmaceutical company with headquarters in Novo Mesto, Slovenia. In 2023, Krka Group's total sales amounted to 1.806 billion euros. The net profit of the Krka Group totalled €313.7 million. Krka sells products to more than 70 countries. In Slovenia the company has production sites in Ločna and Bršljin, Krško, Šentjernej and Ljutomer; several departments are spread across various parts of Ljubljana as well. Krka also has production and distribution centers in Russia, Poland, Croatia, and Germany. At the end of 2023, Krka Group had 12,753 employees. Wikipedia
About Krka dd Novo Mesto
CEOJože Colarič
Employees13.3K
FoundedApr 23, 1954
Headquarters-
SectorPharmaceutical industry
Websitekrka.biz
Previous reportsAll values in EUR
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in EUR
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
485.49M
507.00M
565.77M
553.57M
Cost of goods sold
208.02M
208.84M
223.77M
213.31M
Cost of revenue
208.02M
208.84M
223.77M
213.31M
Research and development expenses
48.88M
44.42M
51.37M
48.68M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
119.68M
158.52M
140.38M
135.48M
Operating expense
167.29M
202.22M
190.40M
182.64M
Total operating expenses
375.31M
411.06M
414.17M
395.95M
Operating income
110.18M
95.94M
151.60M
157.62M
Other non operating income
-2.55M
-3.17M
234.00K
114.00K
EBT including unusual items
96.04M
100.49M
148.27M
171.68M
EBT excluding unusual items
96.04M
98.43M
148.27M
171.68M
Income tax expense
19.06M
20.47M
27.32M
32.46M
Effective tax rate
19.85%
20.37%
18.43%
18.91%
Other operating expenses
-1.26M
-721.00K
-1.35M
-1.53M
Net income
77.08M
80.31M
120.95M
139.31M
Net profit margin
15.88%
15.84%
21.38%
25.17%
Earnings per share
-
-
-
-
Interest and investment income
2.69M
2.85M
2.53M
2.61M
Interest expense
-193.00K
-6.53M
-203.00K
-192.00K
Net interest expenses
2.49M
-3.68M
2.33M
2.42M
Depreciation and amortization charges
-
-
-
-
EBITDA
132.28M
118.66M
174.36M
180.58M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps